DE69324689D1 - Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten - Google Patents

Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten

Info

Publication number
DE69324689D1
DE69324689D1 DE69324689T DE69324689T DE69324689D1 DE 69324689 D1 DE69324689 D1 DE 69324689D1 DE 69324689 T DE69324689 T DE 69324689T DE 69324689 T DE69324689 T DE 69324689T DE 69324689 D1 DE69324689 D1 DE 69324689D1
Authority
DE
Germany
Prior art keywords
melanine
diacylglycerols
melanocytes
increasing
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69324689T
Other languages
English (en)
Inventor
Barbara A Gilchrest
Philip R Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Application granted granted Critical
Publication of DE69324689D1 publication Critical patent/DE69324689D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0626—Melanocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69324689T 1992-08-21 1993-08-20 Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten Expired - Lifetime DE69324689D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/934,872 US5352440A (en) 1988-03-30 1992-08-21 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
PCT/US1993/007853 WO1994004122A2 (en) 1992-08-21 1993-08-20 Use of diacylglycerols for increasing the melanin content in melanocytes

Publications (1)

Publication Number Publication Date
DE69324689D1 true DE69324689D1 (de) 1999-06-02

Family

ID=25466212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69324689T Expired - Lifetime DE69324689D1 (de) 1992-08-21 1993-08-20 Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten

Country Status (6)

Country Link
US (2) US5352440A (de)
EP (1) EP0655907B1 (de)
JP (1) JPH08500595A (de)
CA (1) CA2143003A1 (de)
DE (1) DE69324689D1 (de)
WO (1) WO1994004122A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352440A (en) * 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
US5700450A (en) * 1988-03-30 1997-12-23 The Trustees Of Boston University Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
SE9303444D0 (sv) * 1993-10-20 1993-10-20 Kabi Pharmacia Ab New use of prostaglandins
US5798386A (en) * 1994-08-03 1998-08-25 Cell Therapeutics, Inc. Angiogenic lipid formulations
US5955624A (en) * 1994-08-03 1999-09-21 Cell Therapeutics, Inc. Growth stimulating factors
US6808709B1 (en) * 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
EP0807173B1 (de) 1994-12-30 2007-08-08 Planet Biotechnology, Inc. Verfahren zur herstellung von schutzproteine enthaltende immunoglobuline und ihre verwendung
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
KR980008211A (ko) * 1996-07-27 1998-04-30 유상옥 소목(Caesapinia sappan L.) 추출물을 함유하는 탠닝 화장료
US6214888B1 (en) * 1996-09-18 2001-04-10 Applied Genetics Incorporated Dermatological compounds
US6623724B2 (en) * 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
WO1998055085A1 (en) * 1997-06-04 1998-12-10 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
DK0957903T3 (da) * 1996-09-18 2005-11-21 Applied Genetics Inc Dermatics Norbornen- og norbornandiolforbindelser til behandling af pigmenteringslidelser, neurodegenerative sygdomme eller proliferative hudlidelser
WO1998033379A1 (en) * 1997-02-04 1998-08-06 The General Hospital Corporation A novel method for treating epidermal or dermal conditions
KR100385448B1 (ko) * 1997-02-18 2003-08-19 주식회사 코리아나화장품 브라질린(Brazilin)을주성분으로함유하는탠닝화장료
US6267948B1 (en) 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
WO2002051395A1 (en) * 1998-05-28 2002-07-04 Codon Pharmaceuticals, Inc. Treatment of neurodegenerative diseases
WO2001068576A1 (en) * 2000-03-10 2001-09-20 Applied Genetics Incorporated Dermatics Dermatological compounds
US20060015969A1 (en) * 2000-04-28 2006-01-19 Planet Biotechnology, Inc. Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
DK1290027T3 (da) * 2000-04-28 2010-01-18 Planet Biotechnology Inc Immunoadhæsin til forebyggelse af rhinovirusinfektion
CN1297320C (zh) * 2001-09-06 2007-01-31 株式会社资生堂 毛囊重建系统
US20070118934A1 (en) * 2001-10-26 2007-05-24 Planet Biotechnology, Inc. Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
DE10160966A1 (de) * 2001-12-12 2003-06-26 Beiersdorf Ag Melaninbildendes Haarfärbungsprodukt
US7368131B2 (en) * 2003-02-27 2008-05-06 Supernatural Health, Inc. Method and composition for treating hypopigmentation of the hair and skin
WO2009064492A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Quinoline compounds as melanogenesis modifiers and uses thereof
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
KR100924060B1 (ko) 2007-11-17 2009-10-27 바이오스펙트럼 주식회사 퓨린 유도체를 포함하는 멜라닌 생성 촉진 조성물
US20100040568A1 (en) * 2008-04-30 2010-02-18 Skinmedica, Inc. Steroidal compounds as melanogenesis modifiers and uses thereof
FR2951938B1 (fr) 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
WO2012103487A1 (en) 2011-01-27 2012-08-02 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
FR2978659B1 (fr) 2011-08-05 2014-01-10 Oreal Utilisation de composes cannabinoides pour stimuler la melanogenese
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
EP4171496A2 (de) 2020-06-26 2023-05-03 Universidade do Minho Zusammensetzung zur haarfollikelmodulation, verfahren und verwendungen davon
CA3200959A1 (en) * 2020-11-05 2022-05-12 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treating homocystinuria and other conditions using polyamines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US4618484A (en) * 1983-03-30 1986-10-21 Yale University Composition and method for treatment of melanomas
US4695449A (en) * 1983-03-30 1987-09-22 Yale University Composition and method for treatment of melanomas
US4508706A (en) * 1983-03-30 1985-04-02 Yale University Composition for increasing melanin in mammalian skin and hair
NL8601767A (nl) * 1986-07-07 1988-02-01 Schreuder Chem Adviesbureau Huidbruiningsmiddel.
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
JPH0785714B2 (ja) * 1988-03-30 1995-09-20 トラステイーズ・オブ・タフツ・カレツジ 生体内及び試験管内におけるメラニン含量の増大法及びメラノサイト増殖の誘導法
US5352440A (en) * 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
WO1991007167A1 (en) * 1989-11-09 1991-05-30 Schering-Plough Healthcare Products, Inc. Protein kinase activators as enhancers of melanin production
AU6729290A (en) * 1989-11-09 1991-06-13 Schering-Plough Healthcare Products, Inc. Riboflavin as a tanning enhancer

Also Published As

Publication number Publication date
WO1994004122A2 (en) 1994-03-03
US5750091A (en) 1998-05-12
WO1994004122A3 (en) 1994-03-31
CA2143003A1 (en) 1994-03-03
EP0655907A1 (de) 1995-06-07
US5352440A (en) 1994-10-04
JPH08500595A (ja) 1996-01-23
EP0655907B1 (de) 1999-04-28

Similar Documents

Publication Publication Date Title
DE69324689D1 (de) Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten
DE69219418D1 (de) Zusammensetzung zur Revitalisierung von Nerbgewebe
DE69215383D1 (de) Reduktion des metallionengehaltes in novolakharzen
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
SE458417B (sv) Fixationsinstrument avsett foer anvaendning vid ryggoperationer
DE69318614D1 (de) Einrichtung zur Aufweitung von Blutgefässen
DE69310560D1 (de) Massnahmen zur Verbesserung von digitalen Filtern
DE69617319D1 (de) Dünnfilmübertrager zur Unterschwingungsreduktion
FI930656A (fi) Komposition foer nasal behandling
DE69406302D1 (de) Verwendung von östriolmessungen zur uberwachung tokolytischer therapie
DE59401215D1 (de) Verfahren zur Verhinderung des Reissens von Bambusrohren (mechanisch)
ATE218355T1 (de) Verwendung von mycobacterium zur tumorbehandlung
DE69230653D1 (de) Architektur zur Bearbeitung von Dokumenten
DE69220906D1 (de) Verfahren zur Bestimmung von Retikulozyten
DE69417690D1 (de) Anordnung zur Bestimmung von physikalischen Grössen
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE68916197D1 (de) Zusammensetzung zur in-vivo bzw. in-vitro steigerung des melaningehaltes der melanocyten und deren in-vitro verwendung.
EP0702080A3 (de) Azeotrope aus Octamethyltrisiloxan und N-Propoxypropanol
DE69322850D1 (de) Sauerstoffanalysegerät
DE59307396D1 (de) Dichtring und verwendung desselben
FI960270A0 (fi) Parannuksia laivoihin ja niihin liittyen
ATE202787T1 (de) Makroskopisch orientiertes zelladhäsionsprotein zur wundbehandlung
DE68925918D1 (de) Methode zur Reinigung von Antithrombin-III und Antithrombin-III-Zusammensetzung enthaltend dieses Antithrombin-III
DE69229660D1 (de) Vokoder zur Kodierung und Dekodierung von Sprachsignalen
HK46094A (en) Method of safely providing anesthesia or conscious sedation

Legal Events

Date Code Title Description
8332 No legal effect for de